Moberg Pharma AB sell BiotechBee
Start price
13.05.24
/
70%
€2.37
Target price
31.05.26
€1.50
Performance (%)
-0.84%
End price
14.05.24
€2.35
Summary
This prediction ended on 14.05.24 with a price of €2.35. The SELL prediction by BiotechBee for Moberg Pharma AB closed nearly unchanged from the start price. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Moberg Pharma AB | -2.439% | -2.439% | 3.191% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
According to BiotechBee what are the pros and cons of Moberg Pharma AB for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year